Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Poen has a broad commercial portfolio of prescription and over-the-counter ophthalmic products, including innovative preservative-free glaucoma treatments and lubricating eye drops. The company also offers nutritional supplements for ocular health. No clinical trial data or investigational pipeline was identified in public sources. Recent expansion includes acquisition of Dromex Biotech’s plant to increase manufacturing capacity. Products such as XEGREX LC® for glaucoma and GOTA-PC® for dry eyes are available commercially. No published clinical results were found.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Poen.